The cholesterol ester transfer protein inhibitor, anacetrapib

Ishwarlal Jialal, Jaspreet Kaur

Open source

DOI: 10.1097/mol.0b013e3283474ce1
Published: 2011-06
Container: Current Opinion in Lipidology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Open access: unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
cautionRetraction Watch correction: 1 correction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/mol.0b013e3283474ce1,
  title = {The cholesterol ester transfer protein inhibitor, anacetrapib},
  author = {Ishwarlal Jialal and Jaspreet Kaur},
  year = {2011},
  journal = {Current Opinion in Lipidology},
  doi = {10.1097/mol.0b013e3283474ce1},
  url = {https://doi.org/10.1097/mol.0b013e3283474ce1}
}

RIS

TY  - JOUR
TI  - The cholesterol ester transfer protein inhibitor, anacetrapib
AU  - Ishwarlal Jialal
AU  - Jaspreet Kaur
PY  - 2011
JO  - Current Opinion in Lipidology
DO  - 10.1097/mol.0b013e3283474ce1
UR  - https://doi.org/10.1097/mol.0b013e3283474ce1
ER  -

APA

Jialal, I., & Kaur, J. (2011). The cholesterol ester transfer protein inhibitor, anacetrapib. Current Opinion in Lipidology. https://doi.org/10.1097/mol.0b013e3283474ce1

Source records

crossref · retrieved 2026-09-25T13:08:00.321Z